Sign in
SC 13G

Amended Statement of Ownership

InMed Pharmaceuticals Inc. Filed Acc 0000902664-20-004010

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-12 SCHEDULE 13D · Fairmount Funds Management LLC 19.99%
  2. 2026-06-10 SCHEDULE 13D · Vivo Opportunity Fund Holdings, L.P. 21.7%
  3. 2024-11-14 SC 13G/A · Armistice Capital, LLC 4.99%
  4. 2024-11-12 SC 13G · AdvisorShares Trust 8.77%
  5. 2024-02-14 SC 13G/A · Armistice Capital, LLC 9.99%
  6. 2024-01-04 SC 13G · Sabby Volatility Warrant Master Fund, Ltd. 9.99%
  7. 2023-02-14 SC 13G · Armistice Capital, LLC 9.99%
  8. 2022-02-04 SC 13G/A · Hudson Bay Capital Management LP 3.81%
  9. 2021-02-09 SC 13G · Hudson Bay Capital Management LP 5.97%
  10. 2021-01-20 SC 13G/A · Empery Asset Management, LP 4.99%
Loading p20-2044sc13g.htm…